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Abstract
Background and Objective: Hypercholesterolemia is the leading cause of the development of various diseases that made pharmaceutical
companies turn towards herbal products with fewer side effects. Hyperlipidemic and reactive oxygen species in the body are important
factors for the development of cardiovascular disease such as hypercholesterolemia. The present study investigated the phytochemical
analysis using GCMS and hypolipidemic activity of ethanolic extract of D.  bulbifera  tubers. Materials and Methods: In the present study,
the 70% ethanolic extract of  D.  bulbifera  tubes are  attempted  to  evaluate  for  the  cardio-protective  activity  and  hypolipidemic
activity in High fat diet-induced hyperlipidaemia along with the phytochemical evaluation of the same extract by the GC-MS analysis.
Results: The results showed that 50 mg kgG1 b.wt., of D. bulbifera extract treatment for seven days decreases the level of cholesterol and
LDL significantly (p<0.05). Likewise, 30 days of treatment with 50 mg kgG1 b.wt., of  D.  bulbifera  extract exhibits cardioprotective activity
in high-fat diet-induced hyperlipidemic rats by increasing HDL cholesterol (p<0.05) and decreasing the total cholesterol, LDL and
triglycerides (p<0.05). GC-MS analysis of methanolic fraction from 70% ethanolic extract of D.  bulbifera  showed the presence of fatty
acids in higher concentrations. Conclusion: The  D.  bulbifera  exhibits hypolipidemic and cardio-protective activity in high-fat diet-
induced diseased animals.
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INTRODUCTION
Hyperlipidemia causes about 17 M deaths worldwide
every year1.  It is also an important factor in the development
of cardiovascular disease and atherosclerosis. Atherosclerosis
is a chronic inflammatory disease initiated by multiple factors,
with the solid contribution of endothelial damage related to
lipid peroxidation. This endothelial dysfunction leads to the
permeation of Low Density Lipoproteins (LDL) in the intima
layer, resulting in cardio artery diseases2,3. A plant-based diet
rich in leaves, seeds, fruits, tubers, vegetables and legumes
and low in saturated fat is an effective prescription for anyone
with more severe atherosclerosis. The anti-hyperlipidemic
activity of herbs plays an important role in the reduction of
cardiovascular diseases, which is the top disease that causes
mortality all over the world. Lipid-lowering activities of
medicinal plant for phytochemistry research and drug
development for such a disease are now focused all over the
world. However, there are few herbs available that provide
some bioactive effect for persons with the above disease. The
anti-hyperlipidaemia property in medicinal plant plays a key
role to reduce hypercholesterolemia. Thus, there is an
increasing search for lipid-lowering agents from natural origin.
The  D.  bulbifera  is a glabrous non-spiny climber of 10-20 feet
high with bulbils 1-8 cm in size4. Traditionally it is used as
purgative, de-flatulent, aphrodisiac, rejuvenating, anti-
tubercular, general debility, diabetic disorders and skin
disorders5. Phytochemical screening of D. bulbifera shows
compounds such as phenolics, tannins, carbohydrates, vitamin
C and vitamin D6. Phytochemical studies reveal that the tubers
of Dioscorea species possess high amounts of polyphenolic
compounds7. The D. bulbifera is used as a source of raw
material for the synthesis of cortisone and sex hormone8.
Dioscorea  species  have   been reported to have anti-
oxidative, anti-fungal, anti-mutagenic, hypoglycaemic and
immunomodulatory effects. In this review, an attempt has
been made to give an overview of the anti-hyperlipidemic
activity in traditional medicinal plants. Dioscorea bulbifera L.
(Dioscoreaceae) is found commonly in India. The present
study was designed  to  evaluate  the  70%  ethanolic  extract
of D. bulbifera for the cardio-protective activity and
hypolipidemic activity in high-fat diet-induced hyperlipidemia
along with the phytochemical evaluation of the same extract
by GC-MS analysis. The antihyperlipidemic activity of the
traditional medicinal plants in these communities is more
helpful for the development of new drug lead molecules used
in the protection against hypercholesterolemia. 
MATERIALS AND METHODS
Study area: The tubers of  Dioscorea  bulbifera  was collected
in January, 2019 from the Thovalai, Tamil Nadu, India. The
tubers material was dried (45-50EC), crushed and macerated
in ethanol: water (80:20 v/v) at room temperature for seven
days. After this period, the extract was filtered, concentrated
in a rotary vacuum evaporator and lyophilized. The lyophilized
extract was stored at 4EC.
Collection and identification of plant: Tubers of  D.  bulbifera
were collected from the Thovalai, Trichy district. The plant
material was identified and authenticated at the Department
of Pharmacognosy, Centre for Advanced Research in Indian
System of Medicine, (CARISM), SASTRA University, Thanjavur,
Tamil nadu, India. The herbarium and voucher sample was
prepared and deposited in the Department of Pharmacognosy
and Phytopharmacy, Sastra University (Voucher No. DB-0062)
Thanjavur.
Chemicals and reagents: High-fat diet (western food) was
obtained from Sigma-Aldrich, St. Louis, USA. Other chemicals
used were of analytical grade.
Preparation of extract: The collected plant material was dried
under shade for 15 days. The raw material was pulverized and
used for the extraction. Extraction was carried out using 70%
ethanol by cold percolation method. The extract was
concentrated using a rotary vacuum evaporator at 40EC. The
concentrated extract was preserved in the refrigerator. The
yield of extract was calculated as 2.73%.
GC-MS analysis: The methanolic fraction separated from 70%
ethanolic extract was injected for GC-MS analysis.  The extract
of  D.  bulbifera  (10 mg) was dissolved in methanol. The
sample was analysed by GC-MS on  500 Perkin Elmer using the
following experimental conditions: Column type-elite-5 (5%
diphenyl   95%   dimethyl  polysiloxane),  column  dimension
30 m×0.32 mm), carrier gas-helium 1 mL minG1, column
temperature from 50EC up to 285EC at the rate of 10EC minG1
and 5 min hold, at 285EC, injector and detector temperature
290EC, injection mode split, volume injected: 0.5 µL of a
solution prepared from 2 mg/100 mL in methanol. The total
run time was 30 min. The mass spectrum was taken using
Mass detector-turbo mass gold- Perkin Elmer. Transfer line
temperature 230EC, source temperature 230EC, scan range is
from  40-450  amu,  ionization    technique-Electron   ionization
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technique. The component identification was confirmed by
comparing the mass spectra of compounds with available
NIST and Wiley mass spectral libraries. The quantitative
composition was obtained by peak area normalization8.
Experimental  animals:  Male  Wistar  albino  rats weighing
140-160 g were allowed to have a standard pelleted diet M/s
Hindustan Lever Foods, Bangalore, India and water  ad libitum.
They were housed  under  standard  environmental
conditions. All  the  animal  experiments  were  performed
after getting clearance from Animal ethical clearance
(Clearance No. 7/SASTRA/IAEC/RPP).
Acute toxicity: For evaluation of acute toxicity, the Albino
Wistar rats strain was taken. All the animals were kept in an
identical situation and fed a laboratory diet as per the
prescribed dose. All the animals were adults with an average
age of 6 months. To study the safety of the  D.  bulbifera
extract, the acute toxicity studies were initially carried out
using 70% ethanolic extracts obtained after successive
extraction with solvents of increasing polarity. The animals
were divided into 4 groups of each containing 10 animals. The
methanolic extract of D. bulbifera as a suspension in 5%
Tween 80 were prepared and administered orally at a single
dose ranging from 400-1000 mg kgG1 b.wt., of the rats.
Hypolipidemic activity: Animals were divided into 4 groups
of 10 rats each. Group 1 animals were considered normal and
were fed with a standard diet. Group 2 animals were treated
High   Fat  Diet  (HFD),  group  3  animals  treated  high  fat-diet
along 70% ethanolic extract of D. bulbifera at 50 mg kgG1 and
group 4 animals treated with a high-fat diet along with
standard drug d-fenfluramine at 10 mg kgG1 b.wt., for 30 days.
After 30 days all animals were fasting continued up to 24 hrs.
The blood was collected from the 7th day and 30th day by
retro-orbital puncture under volatile (ether) anaesthesia.
Plasma total cholesterol9,10 triglycerides10,11 and LDL12,13 was
analyzed.
Statistical  analysis:  The  values  have been expressed as
Mean±SD. Analyses were done using students t-test by SPSS
software. 
RESULTS AND DISCUSSION
GC-MS analysis of D. bulbifera extract: GC-MS analysis
showed the presence of maltol, 9,12 octadecadienoic acid
methyl ester and oleic acid methyl ester as the major
compound. Followed by this hexadecanoic acid, methyl ester
and isomaltol (derivatives of flavone and isoflavone) as the
major compounds. Other compounds  are  mentioned  in
Table 1 and the Gas chromatogram of the same are
mentioned in Fig. 1. GC-MS analysis of methanol soluble
compounds of D. bulbifera 70% ethanolic extract has
indicated the presence of fatty acids like octadecadienoic acid
methyl ester and hexadecadienoic acid ethyl ester which are
not reported earlier. The hexadecadienoic acid-diethyl
dimethyl ester with a peak area of 27.97% was found to be
present in a higher concentration. The cardioprotective
activity  of  this  compound  has  not been reported earlier. The
Table 1: GC-MS details of D. bulbifera extract
Peak name Retention time Peak area (%)
Glycerin (C3H8O3; MW: 92) 3.36 1.2958
2-Furanmethanol (C5H6O2; MW: 98) 5.22 5.4114
1,2-Cyclopentanedione (C5H6O2; MW: 98) 6.57 1.3641
Butanedioic acid, 2-hydroxy-2-methyl-, dimethyl ester (C7H12O5; MW: 176) 7.35 1.0719
Isomaltol (C6H6O3; MW: 126) 7.60 2.2491
5-cis-Methyl-1R,3-cis-cyclohexanediol (C7H14O2; MW: 130) 8.53 0.7872
3-Acetylthymine (C7H8N2O3; MW: 168) 9.59 1.7138
1-Butanol, 3-methyl-, formate (C6H12O2; MW: 116) 10.00 10.8687
Maltol (C6H6O3; MW: 126) 10.30 14.1262
4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl- (C6H8O4; MW: 144) 10.92 1.9263
2(3H)-Furanone, dihydro-4-hydroxy- (C4H6O3; MW: 102) 11.10 2.6141
Heptanediamide, N,N'-di-benzoyloxy- (C21H22N2O6; MW: 398) 11.21 0.9567
6-Acetyl-"-d-mannose (C8H14O7; MW: 222) 12.40 0.4625
3,5-Heptadienal, 2-ethylidene-6-methyl- (C10H14O; MW: 150) 13.98 0.4873
Hexadecanoic acid, methyl ester (C17H34O2; MW: 270) 22.94 10.8359
9,12-Octadecadienoic acid, methyl ester (C19H34O2; MW: 294) 25.04 12.7210
Oleic acid, methyl ester (C19H36O2; MW: 296) 25.11 13.2264
Palmitic acid "-monoglyceride (C19H38O4; MW: 330) 26.80 2.8107
2,4-Hexadienedioic acid, 3,4-diethyl-, dimethyl ester (C12H18O4; MW: 226) 27.97 10.0874
1-[2-(5-Hydroxy-1,1-dimethylhexyl)-3-methyl-2-cyclopropen-1-yl] ethanone (C14H24O2; MW: 224) 28.06 4.9834
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Fig. 1: GC-MS chromatogram of D.  bulbifera  extract
Table 2: Acute toxicity study of D. bulbifera
Mortality observed
Dose level Sample ------------------------------------------
(mg kgG1) size After 24 hrs After 72 hrs
400 10 0/10 0/10
600 10 0/10 0/10
800 10 0/10 0/10
1000 10 0/10 0/10
observed cardioprotective activity in the present study might
be due to the presence of anyone compound mentioned in
Table 1 or the action might be due to the synergistic action of
all the mentioned (Table 1) compounds14,15.
In the present experimental  study,  D.  bulbifera  could
not  produce  any  lethality  at  the  oral maximum dose of
1000 mg kgG1 b.wt./day. All the rats were healthy and active at
the time of completion of the experiment reported in Table 2. 
Hypolipidemic activity of D. bulbifera: Rats treated with High
Fat Diet (HFD) increased cholesterol, LDL-c, triglycerides level
and decreased HDL-c levels.  When the 70% ethanolic extract
of  D.  bulbifera  was  given  orally continuously for 1 month
the  rising  trend  of  cholesterol,   LDL-c  and  triglycerides
were significantly less than the normal  control group. The
LDL-c showed a significant decrease under the  influence  of
D. bulbifera, when d-fenfluramine along the cholesterol diet
was administered. The HFD was observed to increase the level
of lipid profile like total cholesterol, LDL and TGL in plasma
(p<0.05), Table 3 results revealed that the  D.  bulbifera
extract-treated group of animals showed a significant
reduction (p<0.001) in cholesterol level. On treating animals
with D. bulbifera extract at the dose of 50  mg  kgG1  b.wt.
Table 4 results showed that the HDL level (*p 0.05) increases
in the treatment group with D. bulbifera tubers extract.
Likewise, the HDL level was seen to be decreased in diseased
animals and increased in treatment (p<0.05, Table 4). 
Similarly, in Table 4 and 5 results displaced the significant
reduction in LDL level and Triglycerides. On treating animals
with D.  bulbifera  extract at the dose of 50 mg kgG1 b.wt., bad
cholesterol such as LDL and triglycerides were found to be
decreased significantly (p<0.05) in Table 5 and 6. Moreover,
Dwivedi13 has explained that the high-fat diet causes an
increase in the level of myocardial lipids. It increases the LDL
cholesterol level in  the blood, which in turn, leads to the
build-up of harmful deposits in the arteries, thus, favouring
coronary heart disease. Moreover, HFD promotes lipolysis in
the myocardium14. Lipolysis results in the release of a large
amount of free fatty acids and triacylglycerol. The decrement
of TGL observed in the present study reveals that D. bulbifera
extracts exhibit hypolipidemic activity.
The  hypolipidemic  activity  of  D.  bulbifera  tubers
extract  can  be  correlated to the presence of flavonoids due
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Table 3: Role of 70% ethanolic extract of D. bulbifera on total cholesterol level among the experimental animals
Total cholesterol level (mg dLG1)
----------------------------------------------------------------------------------------------------------------------------------------------------
Groups Initial After 7 days After 1 month
Normal control 64.32±7.89 63.80±6.52 64.70±8.42
High fat diet (HFD) 61.64±7.32 895.42±49.75** 480.82±40.72*
HFD+D. bulbifera 62.32±4.98 840.44±90.85* 328.50±38.20**
HFD+d-fenfluramine 66.40±5.85 860.52±78.85* 280.50±16.80*
Data were expressed as Mean±SD, n = 10, **p<0.001, *p<0.05
Table 4: Role of 70 % ethanolic extract of D .bulbifera on HDL-c level among experimental animals
HDL-c level (mg dLG1)
----------------------------------------------------------------------------------------------------------------------------------------------------
Groups Initial After 7 days After 1 month
Normal control 18.50±4.33 19.32±4.85 18.37±5.85
High-fat diet (HFD) 19.32±3.85 21.82±5.32* 21.85±4.85*
HFD+D. bulbifera 17.20±2.88 18.60±3.85* 26.20±6.85*
HFD+d-fenfluramine 16.80±3.75 17.32±4.85* 18.55±5.85**
Data were expressed as Mean±SD, n = 10, **p<0.001, *p<0.05, HDL: High-Density Lipoprotein
Table 5: Role of 70% ethanolic extract of D. bulbifera on LDL-c level among experimental animals
LDL-c level (mg dLG1)
----------------------------------------------------------------------------------------------------------------------------------------------------
Groups Initial After 7 days After 1 month
Normal control 21.85±4.78 22.75±5.72 23.22±6.85
High fat diet (HFD) 22.75±5.32 498.50±80.32** 260.40±65.32**
HFD+D. bulbifera 24.85±4.85 510.50±78.53* 88.55±12.10**
HFD+d-fenfluramine 23.42±4.85 330.80±81.32* 94.85±16.85**
Data were expressed as Mean±SD, n = 10, **p<0.001, *p<0.05, LDL: Low-Density Lipoprotein
Table 6: Role of 70% ethanolic extract of D. bulbifera on triglycerides level among experimental animals
Triglycerides level (mg dLG1)
----------------------------------------------------------------------------------------------------------------------------------------------------
Groups Initial After 7 days After 1 month
Normal control 24.85±6.70 30.32±7.85 31.40±6.52
High fat diet (HFD) 28.45±8.12 340.70±64.80** 180.50±12.32**
HFD+D. bulbifera 26.32±4.80 160.55±69.85** 128.50±10.85**
HFD+d-fenfluramine 29.70±4.85 97.50±6.80** 70.85±9.30*
Data were expressed as Mean±SD, n = 10, **p<0.001, *p<0.05
absorption and modifying the activity of lipogenic and
lipolytic enzymes, leading to reduced lipid metabolism16-18, as
observed in hyperlipidemic rats treated with D. bulbifera,
which showed a significant reduction in the levels of total
cholesterol and triglycerides and increases the HDL level. 
Other molecules able to decrease the serum level of
cholesterol are flavonoids and phenolic acid19, also present in
D.  bulbifera.  Interestingly, D.   bulbifera  was able to decrease
both serum level of cholesterol (**p>0.001, Table 3) and total
triglycerides  (**p>0.001, Table 6).  Some  mechanisms  of
high-fat diet-induced hypertriglyceridemia are insulin
resistance in rats20. Although cholesterol in the diet alters the
activity of several enzymes and regulates hepatic
carbohydrate metabolism, leading to hepatic insulin
resistance21 and hypertriglyceridemia, the mechanisms by
which an excess of carbohydrates produces these effects are
unknown21.
Feeding rats with a high dosage of fatty materials (>60%
of total calories in diet) affects lipid metabolism and causes
hyperlipidemia22. Insulin resistance, hyperinsulinemia  and
mild hypertension, which are features associated  with
obesity-related hypertension. Carbohydrates’ feeding evokes
significant alterations particularly in liver TGL23 metabolism
and is reported to be atherogenic due to the induction of
lipogenic enzymes in the liver. In the current study, the
administration of the high-fat diet for 30 days has significantly
increased the glucose, insulin and triglyceride levels like an
earlier study24. Administering D. bulbifera (50 mg kgG1) has
prevented the development of hyperlipidaemia. Lipid changes
observed in high-fat-diet treated rats are noted to have
elevated levels of cholesterol, TGL, LDL and HDL-C. 
Accumulation of cholesterol, TGL and LDL is observed in
tissues. These findings are consistent with the results of
another  study25.  The  increased  conversion of carbon from a
27
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high carbohydrate diet into glycerol-3-phosphate might be
responsible for the elevated level of TGL in high cholesterol
diet-administered animals26.
Feeding a high-fat diet to hyperlipidemic rats produces an
increase in activity of HMG-CoA reductase and the addition of
fructose to cultured rat hepatocytes increases HMG-CoA
reductase by approximately 3-fold27. The D. bulbifera extract
might be an inhibitor of HMG CoA reductase, which is
responsible for the observed decrease in the level of lipid
profile. The ascorbic acid concentration of D. bulbifera is
reported in the previous study28. Vitamin C can inhibit the
formation of ox-LDL in the in  vitro  condition. Even if ascorbic
acid is water-soluble and is not incorporated in LDL particles,
it has been proposed that this Vitamin may prevent LDL
particle oxidation by scavenging free radicals and other
reactive species in an aqueous milieu29. 
The concentration of flavonoids and polyphenolic
compounds of D.  bulbifera  according to Arai  et  al.30 has
noted   that  the  intake  of  flavonoids  inversely  correlates
with the plasma total cholesterol and LDL cholesterol
concentrations. Polyphenols reduce the susceptibility of LDL
to oxidation in in vitro31.
CONCLUSION
This study showed that  D.  bulbifera extract is a rich
source of phytoconstituents such as flavonoids, tannins,
alkaloids, terpenoids and vitamin C. Among the different
extracts of D. bulbifera, 70% ethanolic extract is a loaded
source of secondary metabolites. The pharmacological
evaluation of D. bulbifera has proved that 70% ethanolic
extract of D. bulbifera exhibits hypolipidemic activity by
decreasing the level of total cholesterol, LDL, TGL and
increases the level of HDL.  In  pharmaceutical  companies,
70% ethanolic extract of  D.  bulbifera  can be used as a potent
hypolipidemic and antioxidant activity.
SIGNIFICANCE STATEMENTS
The hypolipidemic  activity  of  natural  D.  bulbifera  can
be correlated to the presence of flavonoids due to their
properties of inhibiting cholesterol biosynthesis and
absorption and modifying the activity of lipogenic and
lipolytic enzymes, leading to reduced lipid metabolism as
observed in hyperlipidemic rats.  The  results  presented  that
D. bulbifera tubers reduce oxidative stress by free radical
scavenging and protect against lipid peroxidation and are also
able to manage hyperlipidemia by decreasing serum level of
cholesterol and  triglycerides and increased serum level of
HDL, similarly to conventional drugs.
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